tiprankstipranks
Trending News
More News >
Msp Recovery, Inc. (MSPR)
:MSPR
US Market

MSP Recovery (MSPR) AI Stock Analysis

Compare
376 Followers

Top Page

MS

MSP Recovery

(NASDAQ:MSPR)

Rating:39Underperform
Price Target:
$1.50
▲(38.89%Upside)
MSP Recovery's stock score is primarily driven by its poor financial performance, indicated by negative financial metrics and high leverage. Technical analysis suggests bearish trends, while valuation concerns are highlighted by a negative P/E ratio. The recent corporate event of lowering the SEPA floor price adds to the financial instability, making it a risky investment.

MSP Recovery (MSPR) vs. SPDR S&P 500 ETF (SPY)

MSP Recovery Business Overview & Revenue Model

Company DescriptionMSP Recovery, Inc. operates as a healthcare recoveries and data analytics company in the United States and Puerto Rico. The company offers claims recovery services, including services to related parties or third parties to assist entities with pursuit of claims recovery rights. It also provides Chase to pay service to assist its healthcare provider clients to identify in the first instance the proper primary insurer at the point of care and thereby avoid making a wrongful payment; and LifeWallet, a platform designed to locate and organize users' medical records. MSP Recovery, Inc. was founded in 2014 and is headquartered in Coral Gables, Florida.
How the Company Makes MoneyMSP Recovery makes money primarily by identifying and recovering improperly paid insurance claims on behalf of its clients, which include healthcare providers and insurers. The company operates on a contingency fee basis, meaning it earns a percentage of the funds recovered from these claims. MSP Recovery uses sophisticated data mining and analytical tools to detect discrepancies in payments and negotiate settlements, thereby securing revenue through successful recoveries. Additionally, partnerships with healthcare organizations and insurers enhance its ability to access claim data and expand its recovery operations.

MSP Recovery Earnings Call Summary

Earnings Call Date:May 14, 2025
(Q1-2024)
|
% Change Since: -43.46%|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted LifeWallet's successful settlements and increased claims recovery income, demonstrating progress in its core business model. However, the company also reported a significant operating loss, primarily due to noncash items. Overall, while there are substantial achievements, the financial results reflect ongoing challenges.
Q1-2024 Updates
Positive Updates
Successful Settlements with Insurers
LifeWallet achieved two comprehensive settlements with multiple property and casualty insurers, resolving claims and establishing a process for future claims. The settlements include provisions for data sharing and a 5-year agreement for binding mediation of Medicare claim liens.
Increased Claims Recovery Income
The company generated claims recovery income of $6 million in Q1 2024, up from $3.5 million in Q1 2023, indicating progress in its recovery strategies.
Expansion of Data Collaboration
LifeWallet entered into a tri-party data collaboration agreement with Palantir Technologies and 28 affiliated settling counterparties to enhance its ability to reconcile Medicare liabilities.
Liquidity and Financial Flexibility
LifeWallet extended its obligations with Virage, Nomura, and Yorkville to 2025, and secured a working capital credit facility with an additional $14 million borrowing capacity.
Negative Updates
Significant Operating Loss
LifeWallet reported an operating loss of $130 million for Q1 2024, with 93% attributed to noncash items such as claims amortization expense.
Intangible Asset Decrease
Total assets decreased by $124 million from December 31, 2023, primarily due to the amortization of intangible assets.
Company Guidance
During the LifeWallet First Quarter 2024 earnings call, the company provided guidance highlighting significant achievements and financial metrics. LifeWallet reached two comprehensive settlements with property and casualty insurers, which included agreements to provide 10 years of historical data and to collaboratively resolve future Medicare claims. These settlements resulted in claims recovery income of $6 million for Q1 2024, an increase from the $3.5 million reported in Q1 2023. The company reported a total operating loss of $130 million, primarily driven by non-cash items, with an adjusted operating loss of $8.7 million after excluding claims amortization expenses. LifeWallet's total assets were valued at $3 billion, with liabilities amounting to $1.8 billion. The company has extended various obligations to 2025 and secured additional liquidity through a working capital credit facility and a Yorkville standby equity purchase agreement, ensuring its ability to meet cash obligations over the next year.

MSP Recovery Financial Statement Overview

Summary
MSP Recovery faces severe financial challenges, including negative income and cash flows, high leverage, and instability in revenue generation. The negative stockholders' equity and inability to maintain positive cash flow are critical concerns for financial health.
Income Statement
25
Negative
MSP Recovery's income statement reveals significant challenges, with negative net income and gross profit margins. The TTM revenue shows a decline compared to previous periods, indicating instability in revenue generation. Additionally, negative EBIT and EBITDA margins highlight ongoing operational inefficiencies and profitability issues.
Balance Sheet
30
Negative
The balance sheet presents a highly leveraged position with a negative stockholders' equity, indicating financial instability. The debt-to-equity ratio cannot be calculated due to negative equity, which is a critical concern. Despite a reasonable amount of cash and short-term investments, the company's total liabilities exceed its total assets, further underscoring potential financial distress.
Cash Flow
20
Very Negative
The cash flow statement highlights negative free cash flow and operating cash flow, suggesting cash management challenges. The company's inability to generate positive free cash flow consistently indicates potential difficulties in sustaining operations without external financing.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue13.09M18.25M7.71M23.42M14.63M13.89M
Gross Profit125.42M8.64M5.56M21.37M14.44M13.71M
EBITDA-2.72B-1.98B-69.22M-13.54M-5.52M-2.97M
Net Income-463.22M-360.50M-56.35M-7.42M-33.09M-24.25M
Balance Sheet
Total Assets1.80B1.92B3.16B3.42B104.01M17.84M
Cash, Cash Equivalents and Short-Term Investments9.07M12.33M11.63M3.66M1.66M11.88M
Total Debt695.97M664.33M679.33M324.25M106.81M24.04M
Total Liabilities2.16B2.05B1.74B1.23B255.41M133.69M
Stockholders Equity-60.82M100.58M272.39M109.69M-155.76M-120.18M
Cash Flow
Free Cash Flow-21.71M-16.65M-42.47M-86.32M1.62M-344.00K
Operating Cash Flow-21.17M-16.12M-40.02M-80.64M2.25M-14.00K
Investing Cash Flow-2.75M-2.73M7.56M-5.68M-2.01M986.00K
Financing Cash Flow21.01M19.54M29.02M99.73M-10.46M9.61M

MSP Recovery Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.08
Price Trends
50DMA
1.56
Negative
100DMA
1.74
Negative
200DMA
2.20
Negative
Market Momentum
MACD
-0.11
Positive
RSI
33.04
Neutral
STOCH
16.48
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MSPR, the sentiment is Negative. The current price of 1.08 is below the 20-day moving average (MA) of 1.34, below the 50-day MA of 1.56, and below the 200-day MA of 2.20, indicating a bearish trend. The MACD of -0.11 indicates Positive momentum. The RSI at 33.04 is Neutral, neither overbought nor oversold. The STOCH value of 16.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MSPR.

MSP Recovery Risk Analysis

MSP Recovery disclosed 95 risk factors in its most recent earnings report. MSP Recovery reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

MSP Recovery Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$17.08M-25.29%26.67%44.02%
60
Neutral
HK$15.58B5.65-7.43%4.32%11.60%-21.06%
49
Neutral
$9.83M-52.79%82.77%-87.95%
39
Underperform
$8.41M-458.99%34.74%-53.67%
$7.82M1.5045.44%
$13.20M-59.91%
34
Underperform
$8.33M-126.03%-100.00%-27.44%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MSPR
MSP Recovery
1.02
-8.95
-89.77%
PRPO
Precipio
12.05
7.17
146.93%
PMCB
PharmaCyte Biotech
1.11
-1.07
-49.08%
IMRN
Immuron
1.78
-0.32
-15.24%
NEUP
Neuphoria Therapeutics
7.13
-1.15
-13.89%
TSBX
Turnstone Biologics Corp.
0.36
-1.90
-84.07%

MSP Recovery Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
MSP Recovery Amends Promissory Note with Nomura
Neutral
Jun 27, 2025

On June 26, 2025, MSP Recovery, Inc. amended its promissory note with Nomura Securities International, increasing the principal to approximately $33.6 million and waiving Nomura’s entitlement to $3 million from the Yorkville SEPA. Additionally, the company has been engaging with Yorkville under a Standby Equity Purchase Agreement, allowing it to sell up to $250 million in shares. This includes issuing convertible promissory notes, with the latest being a $0.8 million note on June 26, 2025, which Yorkville can convert into shares, impacting the company’s financial strategy and shareholder dynamics.

Private Placements and FinancingBusiness Operations and Strategy
MSP Recovery Lowers Floor Price in Yorkville SEPA
Negative
Jun 5, 2025

On June 5, 2025, MSP Recovery and Yorkville agreed to lower the Floor Price under the Yorkville SEPA from $3.75 to $1.00. Hazel and Virage expressed willingness to negotiate additional working-capital funding to support the company’s ongoing claim servicing, which could impact MSP Recovery’s financial operations and stakeholder interests.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 01, 2025